This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
24 Apr 2015

Can a New Dietary Supplement Help Minimise the Risk of Breast Cancer?

In the UK, about 1 in 8 women will develop breast cancer at some point during their lifetime. While there is no guaranteed way to prevent the disease, there are steps that may help lower the risk — especially for those at an increased risk of developing breast cancer.

 

As well as leading a healthy diet and lifestyle, women who are at risk or worried about breast cancer may be able to lower their chances of developing it, by supplementing their diet with a revolutionary new supplement, ProfBiotics Breast. Welcomed by leading cancer experts, it has been developed in consultation with Professor Martyn Caplin, leading cancer specialist and consultant gastroenterologist at London’s Royal Free Hospital, following a comprehensive review of clinical evidence investigating the role of specific nutrients in breast cancer prevention.

 

The supplement has been formulated to contain the specific blend of ingredients to help support breast wellbeing:

• Lycopene (tomato powder 5 mg), which has been increasingly associated with breast well-being. Studies suggest that women with higher circulating levels of lycopene may be at reduced risk of breast cancer
• Vitamin D (12.5 mcg [500 IU]), which has been found to regulate cell death – data suggest there is an association between lower levels of vitamin D and higher rates of breast cancer
• Zinc ([from Citrate] 7.5mg) — studies find that low zinc intake may be linked to breast cancer risk
• Curcumin (extract 25:1 — 240 mg providing 6000 mg whole herb equivalent) , which appears to be useful in preventing human breast cancer development.

 

The formula contains the equivalent of eight teaspoons of turmeric which would be difficult to consume each day through diet alone.

 

Cancer experts have welcomed the initiative. Justin Stebbing, Professor of Cancer Medicine and Oncology at Imperial College London, comments, “Any approach which may help reduce cancer risk utilising diet and appropriate nutrients is of huge potential value for individuals and society. The combinations used in these products are in line with the results of scientific research studying different tumour types and represent a new approach to tackling cancer incidence through diet and nutrient supplementation. The formulations may also have a role during and after cancer treatment for nutritional support, and to counter adverse effects of chemotherapies.”
 

Related News